News & Updates

Combination treatment with trastuzumab deruxtecan (T-DXd) and radiation therapy (RT) may improve clinical outcomes, without compromising safety, in patients with HER2-positive and HER2-low metastatic breast cancer, reveals a study.

The results from the phase III ROP-ET trial demonstrate the potential of ropeginterferon alfa-2b (ropeg) for the treatment of essential thrombocythaemia (ET) across all risk levels in patients who are ineligible for standard cytoreduction.

In the treatment of acute ischaemic stroke in patients with recent direct oral anticoagulant (DOAC) use, intravenous thrombolysis appears to be safe and is associated with improvements in functional outcomes, according to a study.

Sticking to a dietary pattern high in carotenoids and flavonoids during middle age helps prevent the development of frailty later in life, according to a study from Singapore.

Symptoms of overactive bladder (OAC) tend to rise among women receiving both trastuzumab and pertuzumab for HER2-positive positive breast cancer during their treatment, reports a study.

Among several social determinants of health (SDOHs), diet quality is most consistently associated with disease prevalence and severity in metabolic dysfunction-associated steatotic liver disease (MASLD), reports a study.

Influenza immunization at midlife neither increases nor reduces the risk of Parkinson’s disease (PD), as shown in a study.